Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced a …
Equillium Announces Strategic Expansion of Cryptocurrency Treasury Reserve Strategy
view original post